Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $27.5 Million - $30.1 Million
-67,500 Reduced 63.14%
39,400 $16.5 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $11.9 Million - $14.2 Million
34,600 Added 47.86%
106,900 $43.5 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $7.51 Million - $8.41 Million
23,900 Added 49.38%
72,300 $25.4 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $1.42 Million - $1.62 Million
5,000 Added 11.52%
48,400 $15.2 Million
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $2.8 Million - $3.15 Million
9,800 Added 29.17%
43,400 $12.5 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $5.04 Million - $5.62 Million
18,400 Added 121.05%
33,600 $9.73 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $3.29 Million - $4.1 Million
-14,000 Reduced 47.95%
15,200 $4.28 Million
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $6.16 Million - $7.25 Million
27,800 Added 1985.71%
29,200 $7.62 Million
Q4 2021

Feb 08, 2022

SELL
$177.01 - $223.45 $4.21 Million - $5.32 Million
-23,800 Reduced 94.44%
1,400 $307,000
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $30.3 Million - $33.9 Million
-166,800 Reduced 86.88%
25,200 $4.57 Million
Q2 2021

Sep 13, 2021

BUY
$187.49 - $221.1 $36 Million - $42.5 Million
192,000 New
192,000 $38.7 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $126B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.